Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

ABX ADVANCED BIOCHEMICAL COMPOUNDS - BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH

UEI: LAHNMPWWFFJ9CAGE: CD963

ABX ADVANCED BIOCHEMICAL COMPOUNDS - BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH is a federal contractor, registered under UEI LAHNMPWWFFJ9 and CAGE code CD963. It has been awarded $289,861 across 16 federal contracts. Primary work spans Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing, and Analytical Laboratory Instrument Manufacturing. Top awarding agencies include Department Of Health And Human Services and Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

LAHNMPWWFFJ9

CAGE Code

CD963

Entity Structure

International Organization

Established

N/A

Business Classifications

202X

NAICS Codes

325411Medicinal and Botanical Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ABX ADVANCED BIOCHEMICAL COMPOUNDS - BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH specializes in the manufacturing of high-purity biochemical reagents for biomedical research, with a focus on precision-synthesized metal precursor compounds used in diagnostic and therapeutic applications. Their technica...

ABX ADVANCED BIOCHEMICAL COMPOUNDS - BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH specializes in the manufacturing of high-purity biochemical reagents for biomedical research, with a focus on precision-synthesized metal precursor compounds used in diagnostic and therapeutic applications. Their technical expertise lies in the controlled synthesis and formulation of trace-metal standards, including tin-based precursors at ultra-low concentrations, tailored for use in radiopharmaceutical development, molecular imaging, and analytical calibration workflows. The company demonstrates specialized capability in producing GMP-grade reference materials with stringent purity specifications, ensuring traceability and reproducibility in laboratory and clinical research settings. Their differentiation stems from the ability to deliver highly specific, small-batch custom formulations that meet exacting research-grade requirements, particularly for applications requiring isotopic consistency and low contaminant profiles. The contractor has delivered specialized biochemical products to the Department of Health and Human Services, supporting research initiatives requiring certified reference materials for analytical validation and method development. Their engagement reflects a niche role in supplying critical reagents for biomedical laboratories under HHS oversight, likely serving agencies such as NIH or CDC engaged in translational research. Their primary industry focus is medicinal and botanical manufacturing under NAICS 325411, which in practice translates to the production of synthetic biochemical standards and research-grade compounds rather than bulk pharmaceuticals or botanical extracts. This positions them as a specialized supplier within the life sciences supply chain, serving academic, government, and contract research organizations requiring high-integrity reference materials. The entity operates as an X6 structure from Radeberg, Germany, with no publicly disclosed federal certifications. Their geographic presence is centered in Europe, and their government market positioning is defined by targeted, high-precision supply to U.S. biomedical research programs rather than broad-scale procurement contracts.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$273.6K94.4%
Department Of Veterans Affairs$16.2K5.6%
Awards by NAICS
325411 - Medicinal and Botanical Manufacturing$242.1K83.5%
325412 - Pharmaceutical Preparation Manufacturing$27.7K9.6%
334516 - Analytical Laboratory Instrument Manufacturing$20.0K6.9%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in ABX ADVANCED BIOCHEMICAL COMPOUNDS - BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH's top NAICS codes and agencies

NAICS: 334516
New
Federal
Initiator+ Alstra™ Microwave Peptide Synthesizer, US/JP configuration, including an Alstra trade-in
Solicitation # 75N98026Q01052
The National Institutes of Health intends to issue a firm-fixed-price purchase order to Biotage for an Initiator+ Alstra Microwave Peptide Synthesizer in a US/JP configuration, which includes an Alstra trade-in. The government plans to solicit from a single source under the justification that only one responsible source can satisfy the agency's specific technical and functional requirements. Biotage is identified as the sole provider capable of meeting these needs due to proprietary technologies, such as its digital syringe pump reagent delivery system, robotically controlled dual-needle syringe technology, and specialized integrated software. These features are critical to maintaining the reproducibility and continuity of the government's established peptide synthesis processes, as substituting with a different manufacturer would necessitate costly and time-consuming redevelopment and revalidation of existing protocols. While this notice is not a formal request for competitive quotations, the government is inviting interested parties to submit capability statements if they believe they can meet all stated requirements. These statements must be submitted electronically to the designated point of contact no later than 9:00 a.m. EDT on August 31, 2026, referencing Notice No. 75N98026Q01052. The government will review all timely responses to determine whether to proceed with a single-source procurement or move toward a competitive process. An award is anticipated approximately five calendar days after the closing date, provided no other responsible source is identified.
National Institutes Of Health Olao

POSTED

3 days ago

DEADLINE

in 7 days
View Details
NAICS: 334516
New
Federal
Notice of Intent to negotiate sole source contract with SPT Labtech Inc
Solicitation # FD-2026-523
The National Oceanic and Atmospheric Administration, through the Northwest Fisheries Science Center, intends to negotiate a single-source contract with SPT Labtech Inc. for the procurement of the BioMicroLab VC100 instrument. This requirement includes all necessary labor, equipment, and materials to provide the device, along with on-site remote installation, training, and a twelve-month extended service contract. The sole-source determination is based on SPT Labtech being the only manufacturer and supplier capable of providing the specific ultrasonic sensor technology required for robust molecular genetic data generation and the only vendor able to service the instrument using original equipment manufacturer parts. The BioMicroLab VC100 is a non-contact ultrasonic liquid level sensor designed to automate sample volume verification and quality control for various laboratory consumables, such as 96, 48, and 24-format well plates. The system is capable of detecting volume changes down to the sub-10 microliter range and can scan a full 96-well plate in one minute. The contract specifies a delivery deadline of November 1, 2026, with training to be completed by December 1, 2026, and a service contract extending through August 31, 2028. While this is not a request for competitive proposals, other firms that believe they can meet the technical requirements may submit written documentation within 15 days of the notice publication.
National Oceanic And Atmospheric Administration

POSTED

3 days ago

DEADLINE

in 11 days
View Details